Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches

Thyroid

Volumn 8, Issue 8, 1998, Pages 715-726

  Ain, Kenneth B ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; CANCER MORTALITY; CANCER RADIOTHERAPY; CARCINOGENESIS; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; THYROID CARCINOMA; THYROIDECTOMY;

EID: 0031752682     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.715     Document Type: Review

References (134)

1. Landis SH, Murray T, Bolden S, Wingo PA 1998 Cancer statistics, 1998. CA Cancer J Clin 48(l):6-29.
2. Thomas GG Jr, Buckwalter JA 1973 Poorly differentiated neoplasms of the thyroid gland. Ann Surg 177(5):632-642.
3. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991. Cancer 79(3):564-573.
4. Hadar T, Mor C, Shvero J, Levy R, Segal K 1993 Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 19(6): 511-516.
5. Agrawal S, Rao RS, Parikh EM, Parikh HK, Borges AM, Sampat MB 1996 Histologie trends in thyroid cancer 1969-1993: A clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J Surg Oncol 63:251-255.
6. Lampertico P 1993 Anaplastic (sarcomatoid) carcinoma of the thyroid gland. Semin Diag Pathol 10(2):159-168.
7. Bakiri F, Djemli FK, Mokrane LA, Djidel FK 1998 The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 82(6):1146-1153.
8. Carcangiu ML, Steeper T, Zampi G, Rosai J 1985 Anaplastic thyroid carcinoma: A study of 70 cases. Am J Clin Pathol 83(2):135-158.
9. Demeter JG, De Jong SA, Lawrence AM, Paloyan E 1991 Anaplastic thyroid carcinoma: Risk factors and outcome. Surgery 110(6):956-963.
10. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA 1990 Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases. Cancer 66(2):321-330.
11. Nel CJC, van Heerden JA, Goellner JR, Gharib H, McConahey WM, Taylor WF, Grant CS 1985 Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases. Mayo Clin Proc 60(l):51-58.
12. Carter N, Milroy CM 1996 Thyroid carcinomaca using fatal laryngeal occlusion. J Laryngol Otol 110:1176-1178.
13. Lee WC, Walsh RM 1996 Anaplastic thyroid carcinoma presenting as a pharyngeal mass with ball-valve type obstruction of the larynx. J Laryngol Otol 110:1078-1080.
14. Lip GYH, Jaap AJ, McCruden DC 1992 A presentation of anaplastic carcinoma of the thyroid with symptomatic intra-abdominal metastases. Br J Clin Pract 46(2):143-144.
15. Phillips DL, Benner KG, Keeffe EB, Traweek ST 1987 Isolated metastasis to small bowel from anaplastic carcinoma. J Clin Gastroenterol 9(5):563-567.
16. Glikson M, Feigin RD, Libson E, Rubinow A 1990 Anaplastic thyroid carcinoma in a retrosternal goiter presenting as fever of unknown origin. Am J Med 88:81-82.
17. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr 1978 Anaplastic carcinoma of the thyroid: A review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 41(6):2267-2275.
18. Spires JR, Schwanz MR, Miller RH 1988 Anaplastic thyroid carcinoma: Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 114(l):40-44.
19. Rossi R, Cady B, Meissner WA, Sedgwick CE, Werber J 1978 Prognosis of undifferentiated carcinoma and lymphoma of the thyroid. Am J Surg 135:589-596.
20. Rafla S 1969 Anaplastic tumors of the thyroid. Cancer 23(3):668-677.
21. Nishiyama RH, Dunn EL, Thompson NW 1972 Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer 30(1):113-127.
22. Rosai J, Saxén EA, Woolner L 1985 Session HI: Undifferentiated and poorly differentiated carcinoma. Sem Diag Pathol 2(2):123-136.
23. Jereb B, Stjernswärd J, Löwhagen T 1975 Anaplastic giantcell carcinoma of the thyroid: A study of treamtent and prognosis. Cancer 35(5):1293-1295.
24. LiVolsi VA 1990 Surgical Pathology of the Thyroid. Philadelphia, W.B. Saunders Co., 1990:253-274.
25. Gaffey MJ, Lack EE, Christ ML, Weiss LM 1991 Anaplastic thyroid carcinoma with osteoclast-like giant cells: a clinicopathologic, immunohistochemical, and ultrastructural study. Am J Surg Pathol 15(2):160-168.
26. Ordóñez NG, El-Naggar AK, Hickey RC, Samaan NA 1991 Anaplastic thyroid carcinoma: immunocytochemical study of 32 cases. Am J Clin Pathol 96(l):15-24.
27. Basolo F, Pollina L, Fontanini G, Fiore L, Pacini F, Baldanzi A 1997 Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression. Br J Cancer 75(4):537-541.
28. Wolf BC, Sheahan K, DeCoste D, Variakojis D, Alpern HD, Haselow RE 1992 Immunohistochemical analysis of small cell tumors of the thyroid gland: An Eastern Cooperative Oncology Group study. Hum Pathol 23(11):1252-1261.
29. Hölting T, Möller P, Tschahargane C, Meybier H, Buhr H, Herfarth C 1990 Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma. World J Surg 14(3):291-295.
30. Nusynowitz ML 1991 Differentiating anaplastic thyroid carcinomas. J Nucl Med 32(7):1363-1364.
31. LiVolsi VA, Brooks JJ, Arendash-Durand B 1987 Anaplastic thyroid tumors: Immunohistology. Am J Clin Pathol 87:434-442.
32. Shvero J, Gal R, Avidor I, Hadar T, Kessler E 1988 Anaplastic thyroid carcinoma: A clinical, histologic, and immunohistochemical study. Cancer 62(2):319-325.
33. Lamovec J, Zidar A, Zidanik B 1994 Epithelioid angiosarcoma of the thyroid gland: Report of two cases. Arch Pathol Lab Med 118:642-646.
34. Kawahara E, Nakanishi I, Terahata S, Ikegaki S 1988 Leiomyosarcoma of the thyroid gland: A case report with a comparative study of five anaplastic carcinomas. Cancer 62(12):2558-2563.
35. Thompson LDR, Wenig BM, Adair CF, Shmookler BM, Heffess CS 1997 Primary smooth muscle tumors of the thyroid gland. Cancer 79(3):579-587.
36. Wan S-K, Chan JKC, Tang S-K 1996 Paucicellular variant of anaplastic thyroid carcinoma: A mimic of Riedel's thyroiditis. Am J Clin Pathol 105(4):388-393.
37. Blasius S, Edel G, Grünen J, Böcker W, Schmid KW 1994 Anaplastic thyroid carcinoma with osteosarcomatous differentiation. Pathol Res Pract 190:507-510.
38. Donnell CA, Pollock WJ, Sybers WA 1987 Thyroid carcinosarcoma. Arch Pathol Lab Med 111:1169-1172.
39. Pascal-Vigneron V, Schneegans O, Weryha G, Floquet J, Olivier P, Mayot D, LeClere J 1993 Osteogenic anaplastic carcinoma of the thyroid. Thyroid 3(4):319-323.
40. Harada T, Shimaoka K, Katagiri M, Shimizu M, Hosoda Y, Ito K 1994 Rarity of squamous cell carcinoma of the thyroid: Autopsy review. World J Surg 18(4):542-546.
41. Simpson WJ, Carruthers J 1988 Squamous cell carcinoma of the thyroid gland. Am J Surg 156:44-46.
42. Zakowski MF, Schlesinger K, Mizrachi HH 1992 Cytologic features of poorly differentiated "insular" carcinoma of the thyroid: A case report. Acta Cytol 36(4):523-526.
43. Pietribiasi F, Sapino A, Papotti M, Bussolati G 1990 Cytologie features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol 94(6):687-692.
44. Justin EP, Seabold JE, Robinson RA, Walker WP, Gurll NJ, Hawes DR 1991 Insular carcinoma: A distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med 32(7):1358-1363.
45. Bal C, Padhy AK, Panda S, Kumar L, Basu AK 1993 "Insular" carcinoma of thyroid: A subset of anaplastic thyroid malignancy with a less aggressive clinical course. Clin Nucl Med 18(12):1056-1058.
46. Hassoun AAK, Hay ID, Goellner JR, Zimmerman D 1997 Insular thyroid carcinoma in adolescents: A potentially lethal endocrine malignancy. Cancer 79(5):1044-1048.
47. Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S, Belfiore A 1997 Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 82(3):735-738.
48. McDonald RJ, Wu S-Y, Jensen JL, Parker LN, Lyons KP, Moran EM, Blahd WH 1991 Malignant transformation of a Hürthle cell tumor: Case report and survey of the literature. J Nucl Med 32(6):1266-1269.
49. Harada T, Ito K, Shimaoka K, Hosoda Y, Yakumaru K 1977 Fatal thyroid carcinoma: Anaplastic transformation of adenocarcinoma. Cancer 39(6):2588-2596.
50. Hutter RVP, Tollefsen HR, de Cosse JJ, Foote FW Jr, Frazell EL 1965 Spindle and giant cell metaplasia in papillary carcinoma of the thyroid. Am J Surg 110:660-668.
51. Wallin G, Bäckdahl M, Tallroth-Ekman E, Lundell G, Auer G, Löwhagen T 1989 Co-existent anaplastic and well differentiated thyroid carcinomas: A nuclear DNA study. Eur J Surg Oncol 15(l):43-48.
52. Galera-Davidson H, Bibbo M, Dytch HE, González-Cámpora R, Fernández A, Wied GL 1987 Nuclear DNA in anaplastic thyroid carcinoma with a differentiated component. Histopathology 11:715-722.
53. Mark J, Ekedahl C, Dahlenfors R, Westermark B 1987 Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas 107:163-174.
54. Ekman ET, Wallin G, Bäckdahl M, Löwhagen T, Auer B 1989 Nuclear DNA content in anaplastic giant-cell thyroid carcinoma. Am J Clin Oncol 12(5):442-446.
55. Klemi PJ, Joensuu H, Eerola E 1988 DNA aneuploidy in anaplastic carcinoma of the thyroid gland. Am J Clin Pathol 89(2):154-159.
56. Yoshida A, Asaga T, Masuzawa C, Kawahara S, Yanoma S, Shimizu A, Harada M 1993 The growth activity and DNA ploidy in anaplastic carcinoma transplanted to nude mice. Nippon Geka Gakkai Zabshi 94(2):177-181.
57. Fisher ER, Gregorio R, Shoemaker R, Horvat B, Hubay C 1974 The derivation of so-called "giant-cell" and "spindlecell" undifferentiated thyroidal neoplasms. Am J Clin Pathol 61(5):680-695.
58. Matias-Guiu X, Villanueva A, Cuatrecasas M, Capella G, De Leiva A, Prat J 1996 p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma. Pathol Res Pract 192:1242-1249.
59. Dobashi Y, Sugimura H, Sakamoto A, Mernyei M, Mori M, Oyama T, Machinami R 1994 Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn Mol Pathol 3(1):9-14.
60. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang S-H, Koeffler HP 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184.
61. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi Y, Dohi K, Nakamura N, Akiyama M 1993 Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn J Cancer Res 84:526-531.
62. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I, Takai S 1993 p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83:1293-1298.
63. Soares P, Cameselle-Teijeiro J, Sobrinho-Simōes M 1994 Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopath 24:205-210.
64. Zou M, Shi Y, Farid NR 1993 p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab 77(4):1054-1058.
65. Hoang-Vu C, Dralle H, Scheumann G, Maenhaut C, Horn R, von zur Mühlen A, Brabant G 1992 Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol 100:51-56.
66. Zou M, Shi Y, Al-Sedairy S, Farid NR 1993 High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer 68:385-388.
67. Stringer BM, Rowson JM, Parkar MH, Seid JM, Hearn PR, Wynford-Thomas D, Ingemansson S, Woodhouse N, Goyns MH 1989 Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas. Experientia 45:372-376.
68. Yoshida A, Asaga T, Masuzawa C, Kawahara S 1994 Alteration of tumorigenicity in undifferentiated thyroid carcinoma cells by introduction of normal chromosome 11. J Surg Oncol 55:170-174.
69. Us-Krasovec M, Golouh R, Auersperg M, Besic N, Ruparcic-Oblak L 1996 Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol 40(5):953-958.
70. Bauman ME, Tao L-C 1995 Cytopathology of papillary carcinoma of the thyroid with anaplastic transformation: A case report. Acta Cytol 39(3):525-529.
71. Berry B, MacFarlane J, Chan N 1990 Osteoclastomalike anaplastic carcinoma of the thyroid: Diagnosis by fine needle aspiration cytology. Acta Cytol 34(2):248-250.
72. Lee JS, Lee MC, Park CS, Juhng SW 1996 Fine needle aspiration cytology of anaplastic carcinoma with osteoclastlike giant cells of the thyroid. Acta Cytol 40:1309-1312.
73. Pimpl W, Rieger R, Winkler J, Boeckl O, Galvan G 1990 Wert der präoperativen feinnadelpunktionszytologie in der diagnose hochmaligner schilddrüsentumoren. Wiener Klinische Wochenschrift 102(9):244-247.
74. Loré JM Jr 1991 Surgery for advanced thyroid malignancy. Otolaryngol Clin North Am 24(6):1295-1319.
75. Tan RK, Finley RK III, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP 1995 Anaplastic carcinoma of the thyroid: A 24-year experience. Head Neck 17:41-48.
76. Junor EJ, Paul J, Reed NS 1992 Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18:83-88.
77. Kobayashi T, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, Monden M 1996 Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 18:36-11.
78. Hermann M, Kober F, Hollinsky C, Heiss A 1990 Reeingriffe bei anaplastischen karzinomen und Sarkomen der Schilddrüse. Wiener Klinische Wochenschrift 102(9):260-264.
79. Hötling T, Meybier H, Buhr H 1990 Stellenwert der tracheotomie in der behandlung des respiratorischen notfalls beim anaplastichen schilddrüsenkarzinom. Wiener Klinische Wochenschrift 102(9):264-266.
80. Levendag PC, De Porre PMZR, van Putten WLJ 1993 Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiation Oncol Biol Phys 26(1):125-128.
81. Kim JH, Leeper RD 1983 Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy: A new approach. Cancer 52(6):954-957.
82. Kim JH, Leeper RD 1987 Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60:2372-2375.
83. Wong CS, Van Dyk J, Simpson WJ 1991 Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 20:3-9.
84. Simpson WJ 1980 Anaplastic thyroid carcinoma: a new approach. Can J Surg 23(1):25-27.
85. Tennvall J, Tallroth E, El Hassan A, Lundell G, Kerman M, Biörklund A, Blomgren H, Löwhagen T, Wallin G 1990 Anaplastic thyroid carcinoma: Doxorubicin, hyperfractionated radiotherapy and surgery. Acta Oncol 29(8): 1025-1028.
86. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S 1994 Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Cancer 74(4):1348-1354.
87. Poster DS, Bruno S, Penta J, Pina K, Catane R 1981 Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland. Cancer Clin Trials 4: 301-307.
88. Gottlieb JA, Hill CS, Jr., Ibanez ML, Clark RL 1972 Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients. Cancer 30(3):848-853.
89. Gottlieb JA, Hill CS, Jr 1974 Chemotherapy of thyroid cancer with Adriamycin. Experience with 30 patients. N Engl J Med 290(4):193-197.
90. Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, De-Conti R 1985 A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56(9):2155-2160.
91. Shimaoka K 1980 Adjunctive management of thyroid cancer: Chemotherapy. J Surg Oncol 15:283-286.
92. Ahuja S, Ernst H 1987 Chemotherapy of thyroid carcinoma. J Endocrinol Invest 10:303-310.
93. Hoskin PJ, Harmer C 1987 Chemotherapy for thyroid cancer. Radiother Oncol 10:187-194.
94. Williams SD, Birch R, Einhorn LH 1986 Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: A Southeastern Cancer Study Group trial. Cancer Treat Rep 70(3):405-407.
95. Asakawa H, Kobayashi T, Komoike Y, Maruyama H, Nakano Y, Tamaki Y, Matsuzawa Y, Monden M 1997 Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma. Anticancer Res 17:2757-2762.
96. De Besi P, Busnardo B, Toso S, Girelli ME, Nacamulli D, Simioni N, Casara D, Zorat P, Fiorentino MV 1991 Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest 14:475-480.
97. Sokal M, Harmer CL 1978 Chemotherapy for anaplastic carcinoma of the thyroid. Clin Oncol 4:3-10.
98. Bukowski RM, Brown L, Weick JK, Groppe CW, Purvis J 1983 Combination chemotherapy of metastatic thyroid cancer: phase II study. Am J Clin Oncol 6:579-581.
99. Kober F, Heiss A, Keminger K, Kepisch D 1990 Chemotherapie hochmaligner schilddrüsentumore. Weiner Klinische Wochenschrift 102(9):274-276.
100. Ekman ET, Lundell G, Tennvall J, Wallin G 1990 Chemotherapy and multimodality treatment in thyroid carcinoma. Otolaryngol Clin North Am 23(3):523-527.
101. Satake S, Sugawara I, Watanabe M, Takami H 1997 Lack of a point mutation of human DNA topoisomerase II in multidrug-resistant anaplastic thyroid carcinoma cell lines. Cancer Lett 116:33-39.
102. Loe DW, Deeley RG, Cole SPC 1996 Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 32A(6):945-957.
103. Lehnert M 1996 Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 32A(6):912-920.
104. Venkataraman GM, Yatin M, Ain KB. MDR1 and MRP1 mRNA expression in primary thyroid cancers and cell lines. 79th Annual Meeting of the Endocrine Society. Minneapolis, MN, 1997: p 248.
105. Auersperg M, Us-Krasovec M, Petrie G, Pogacnik A, Besic N 1990 Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma. Wien Klin Wochenschr 102(9):267-270.
106. Schlumberger M, Parmentier C, Delisle M-J, Couette J-E, Droz J-P, Sarrazin D 1991 Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 67(3): 564-566.
107. Tallroth E, Wallin G, Lundell G, Löwhagen T, Einhorn J 1987 Multimodality treatment in anaplastic giant cell thyroid carcinoma. Cancer 60(7):1428-1431.
108. Werner B, Abele J, Alveryd A, Björklund A, Franzén S, Granberg P-O, Landberg T, Lundell G, Löwhagen T, Sundblad R, Tennvall J 1984 Multimodal therapy in anaplastic giant cell thyroid carcinoma. World J Surg 8(1):64-70.
109. Serrano M, Monroy C, Rodriguez-Garcia JL, Pais JR, Fernandez-Garrido M 1994 Tratamiento combinado del carcinoma anaplásico de tiroides. Ann Med Intern (Madrid) 11(6):288-290.
110. Casterline PF, Jaques DA, Blom H, Wartofsky L 1980 Anaplastic giant and spindle-cell carcinoma of the thyroid: A different therapeutic approach. Cancer 45(7):1689-1692.
111. Sweeney PJ, Haraf DJ, Recant W, Kaplan EL, Yokes EE 1996 Anaplastic carcinoma of the thyroid. Ann Oncology 7:739-744.
112. Yoshida A, Fukazawa M, Ushio H, Aiyoshi Y, Soeda S, Ito K 1989 Study of cell kinetics in anaplastic thyroid carcinoma transplanted to nude mice. J Surg Oncol 41:1-4.
113. Gioanni J, Zanghellini E, Mazeau C, Zhang D, Courdi A, Farger M, Lambert JC, Duplay H, Schneider M 1991 Caractérisation d'une lignée cellulaire humaine provenant d'un carcinome anaplasique de la thyroïde. Bull Cancer 78:1053-1062.
114. Boghaert ER, Ain KB, Taylor K, Greenberg VL, Fowler C, Zimmer SG 1996 Quantitative and qualitative differences in growth, invasion, and metastasis of an anaplastic and a papillary human thyroid cancer cell line in vitro and in vivo. J Clin Exp Metastases 14(5):440-450.
115. Ain KB, Ishizawar RC, Taylor KD 1994 Suramin inhibits growth of differentiated and anaplastic human thyroid carcinomas in monolayer and spheroid cultures with disparate effects in vivo. p. 375, 76th Annual Meeting of the Endocrine Society. Anaheim, CA.
116. Pályi I, Péter I, Daubner D, Vincze B, Lõrincz I 1993 Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Archiv B Cell Pathol 63:263-269.
117. Abe Y, Ichikawa Y, Muraki T, Ito K, Homma M 1981 Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: Absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. J Clin Endocrinol Metab 521:23-28.
118. Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Colletta G 1997 Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res 57:2071-2076.
119. Heldin N-E, Gustavsson B, Claesson-Welsh L, Hammacher A, Mark J, Heldin C-H, Westermark B 1988 Aberrant expression of receptors for platelet-derived growth factor in an anaplastic thyroid carcinoma cell line. Proc Natl Acad Sci USA 85(12):9302-9306.
120. Itoh K, Fukuda K, Matsuzaki T, Takao S, Ohyama M 1989 Human endothelial cell growth factors derived from thyroid anaplastic cell carcinoma. Laryngoscope 99(5):533-537.
121. Tanaka Y, Kubota K, Sasaki N, Takaku F, Uchimura H 1991 Growth stimulating activity secreted by human anaplastic thyroid carcinoma cells. Endocrinol Japan 38(4):413-420.
122. Aust G, Eichler W, Laue S, Lehmann I, Heldin N-E, Lotz O, Scherbaum WA, Dralle H, Hoang-Vu C 1997 CD97: A dedifferentiation marker in human thyroid carcinoma. Cancer Res 57:1798-1806.
123. Ain KB, Taylor KD, Tofiq S, Venkataraman G 1997 Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82(6):1857-1862.
124. Ain KB, Taylor KD 1994 Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78(5):1097-1102.
125. Iwasa K, Noguchi M, Mori K, Ohta N, Miyazaki I, Nonomura A, Mizukami Y, Nakamura S, Michigishi T 1995 Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): Report of a case. Surg Today 25:158-160.
126. Yoshida M, Matsuzaki H, Sakata K, Takeya M, Kato K, Mizushima S, Kawakita M, Takatsuki K 1992 Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma. Cancer Res 52:464-469.
127. Oka Y, Kobayashi T, Fujita S, Matsuura N, Okamoto S, Asakawa H, Murata A, Mori T 1993 Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines. In Vitro Cell Dev Biol 29A:537-542.
128. Aust G, Hofmann A, Laue S, Ode-Hakim S, Scherbaum WA 1996 Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-lα and tumour necrosis factor-α. J Endocrinol 151:277-285.
129. Baba M, Kobayashi T, Oka Y, Yagyu T, Tamaki Y, Takeda T, Monden T, Shimano T, Tsuji Y, Murakami H, Mori T 1993 Preparation of a human monoclonal antibody derived from cervical lymph nodes of a patient with anaplastic carcinoma of the thyroid. Hum Antibod Hybridomas 4:181-185.
130. Asakawa H, Kobayashi T, Komoike Y, Yanagawa T, Takahashi M, Wakasugi E, Maruyama H, Tamaki Y, Matsuzawa Y, Monden M 1996 Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis. J Clin Endocrinol Metab 81(10):3547-3552.
131. Wenisch HJC, Wagner RH, Schumm-Draeger P-M, Encke A 1986 Cytostatic drug therapy in anaplastic thyroid carcinoma. World J Surg 10(5):762-769.
132. Ain KB, Tofiq S, Taylor KD 1996 Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. J Clin Endocrinol Metab 81(10): 3650-3653.
133. 211At α-particle radiotherapy for undifferentiated thyroid cancer. Acta Radiologica Suppl 376:174-175.
134. Cobb LM, Harrison A, Dudley NE, Carr TEF, Humphreys JA 1989 Relative concentration of astatine-211 and iodine-125 by human fetal thyroid and carcinoma of the thyroid in nude mice. Radiother Oncol 13:203-209.